TG2 is up-regulated during cardiac hypertrophy and heart failure in animal models, whereas its activity (GTP binding and GTPase) has been found to be down-regulated in patients with ischemic and dilated cardiomyopathies (Sane et al. 2007). The gene discussed is TGM2; the disease is cardiac hypertrophy.